Wang Song, Shu Jie-Zhi, Cai Yi, Bao Zheng, Liang Qing-Mo
Department of Oncosurgery, Affiliated Nanhua Hospital, University of South China, Hengyang, China.
Asian Pac J Cancer Prev. 2012;13(6):2813-8. doi: 10.7314/apjcp.2012.13.6.2813.
Considerable evidence suggests that metadherin (MTDH) is a potentially crucial mediator of tumor malignancy and an important therapeutic target for simultaneously enhancing chemotherapy efficacy and reducing metastasis risk. Inhibition of MTDH expression by RNA interference has been shown in several previous research, but silencing MTDH expression by microRNA (miRNA) interference in breast cancer has not been established. In the present study, we investigated the role of MTDH-miRNA in down-regulation of proliferation, motility and migration of breast carcinoma cells.
Expression vectors of recombinant plasmids expressing artificial MTDH miRNA were constructed and transfected to knockdown MTDH expression in MDA-MB-231 breast cancer cells. Expression of MTDH mRNA and protein was detected by RT-PCR and Western blot, respectively. MTT assays were conducted to determine proliferation, and wound healing assays and transwell migration experiments for cell motility and migration.
Transfection of recombinant a plasmid of pcDNA-MTDH-miR-4 significantly suppressed the MTDH mRNA and protein levels more than 69% in MDA-MB-231 breast cancer cells. This knockdown significantly inhibited proliferation, motility and migration as compared with controls.
MTDH-miRNA may play an important role in down- regulating proliferation, motility and migration in breast cancer cells, and should be considered as a potential small molecule inhibitor therapeutic targeting strategy for the future.
大量证据表明,黏附素(MTDH)可能是肿瘤恶性程度的关键调节因子,也是同时提高化疗疗效和降低转移风险的重要治疗靶点。先前的多项研究已表明RNA干扰可抑制MTDH表达,但在乳腺癌中通过微小RNA(miRNA)干扰沉默MTDH表达尚未得到证实。在本研究中,我们探讨了MTDH-miRNA在下调乳腺癌细胞增殖、运动和迁移能力方面的作用。
构建表达人工MTDH miRNA的重组质粒表达载体,并转染至MDA-MB-231乳腺癌细胞中以敲低MTDH表达。分别通过RT-PCR和蛋白质印迹法检测MTDH mRNA和蛋白质的表达。进行MTT试验以测定细胞增殖情况,并通过伤口愈合试验和Transwell迁移实验检测细胞运动和迁移能力。
转染pcDNA-MTDH-miR-4重组质粒可使MDA-MB-231乳腺癌细胞中的MTDH mRNA和蛋白质水平显著降低超过69%。与对照组相比,这种敲低显著抑制了细胞增殖、运动和迁移能力。
MTDH-miRNA可能在下调乳腺癌细胞的增殖、运动和迁移能力方面发挥重要作用,应被视为未来潜在的小分子抑制剂治疗靶向策略。